KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non-Current Assets: 2020-2024

Historic Non-Current Assets for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2024 value amounting to $774.7 million.

  • Ginkgo Bioworks Holdings' Non-Current Assets fell 16.53% to $683.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $683.1 million, marking a year-over-year decrease of 16.53%. This contributed to the annual value of $774.7 million for FY2024, which is 16.74% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Non-Current Assets stood at $774.7 million for FY2024, which was up 16.74% from $663.6 million recorded in FY2023.
  • Ginkgo Bioworks Holdings' 5-year Non-Current Assets high stood at $1.1 billion for FY2022, and its period low was $248.6 million during FY2020.
  • Its 3-year average for Non-Current Assets is $842.5 million, with a median of $774.7 million in 2024.
  • Its Non-Current Assets has fluctuated over the past 5 years, first soared by 213.05% in 2022, then tumbled by 39.08% in 2023.
  • Ginkgo Bioworks Holdings' Non-Current Assets (Yearly) stood at $248.6 million in 2020, then soared by 39.96% to $347.9 million in 2021, then skyrocketed by 213.05% to $1.1 billion in 2022, then tumbled by 39.08% to $663.6 million in 2023, then increased by 16.74% to $774.7 million in 2024.